Form 8-K - Current report:
SEC Accession No. 0001641172-25-014322
Filing Date
2025-06-09
Accepted
2025-06-09 16:30:26
Documents
16
Period of Report
2025-06-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 53721
2 EX-10.1 ex10-1.htm EX-10.1 92700
3 EX-99.1 ex99-1.htm EX-99.1 25672
  Complete submission text file 0001641172-25-014322.txt   413137

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cdt-20250603.xsd EX-101.SCH 3882
5 XBRL DEFINITION FILE cdt-20250603_def.xml EX-101.DEF 26777
6 XBRL LABEL FILE cdt-20250603_lab.xml EX-101.LAB 37006
7 XBRL PRESENTATION FILE cdt-20250603_pre.xml EX-101.PRE 25401
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6154
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 251034512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)